ABBOTT LABORATORIES | 2013 | FY | 3

Note 4 — Accumulated Other Comprehensive Income

        The components of the changes in accumulated other comprehensive income from continuing operation, net of income taxes, are as follows: (in millions)

 
   Cumulative
Foreign
Currency
Translation
Adjustments		   Net
Actuarial
Losses and
Prior
Service
Costs and
Credits		   Cumulative
Unrealized
Gains on
Marketable
Equity
Securities		   Cumulative
Gains on
Derivative
Instruments
Designated as
Cash Flow
Hedges		   Total  

Balance at December 31, 2012

   $ (79 ) $ (3,596 ) $ 31   $ 50   $ (3,594 )
                       
​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​

Separation of AbbVie

     (400 )   1,402     —     8     1,010  
                       
​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​

Other comprehensive income (loss) before reclassifications

     (239 )   771     22     (23 )   531  

Income (loss) amounts reclassified from accumulated other comprehensive income (a)

     —     111     (40 )   (30 )   41  
                       
​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​

Net current period comprehensive income (loss) from continuing operations

     (239 )   882     (18 )   (53 )   572  
                       
​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​

Balance at December 31, 2013

   $ (718 ) $ (1,312 ) $ 13   $ 5   $ (2,012 )
                       
​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​
​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​
                       
(a)
Reclassified amounts for foreign currency translation are recorded in the Consolidated Statement of Earnings as Net Foreign exchange loss (gain); gains on marketable equity securities are recorded as Other (income) expense and gains/losses related to cash flow hedges are recorded as Cost of product sold. Net actuarial losses and prior service cost is included as a component of net periodic benefit plan cost — see Note 12 for additional information.

us-gaap:ComprehensiveIncomeNoteTextBlock